This study evaluates prospectively the relationship between impaired g
lucose tolerance (IGT) and blood pressure. From a population of 1376 m
en and women aged 40-59 years, all those with IGT (n = 54) plus 133 ag
e- weight- and sex-matched normoglycaemic control subjects were select
ed after excluding treated hypertensive patients. Blood pressure, fast
ing and postload blood glucose and plasma insulin were measured. At 11
.5 years after the first visit 76% of the IGT patients and 80% of the
control subjects were re-examined. At baseline blood pressure was sign
ificantly higher in IGT patients than in control subjects (systolic 13
5.5 +/- 2.3 vs 127.9 +/- 1.4 mm Hg, p < 0.001; and diastolic 88.0 +/-
1.5 vs 84.7 +/- 0.7 mm Hg, p < 0.05) independent of age, gender, weigh
t, antihypertensive medication and insulinaemia. Accordingly, hyperten
sion was more frequent in subjects with IGT (odds ratio 2.1, 95% confi
dence, interval (CI) 0.9-4.9). Postload insulin was significantly asso
ciated with hypertension - both at univariate and multivariate analysi
s - in normoglycaemic subjects, but not in those with IGT. At follow-u
p systolic blood pressure increased in both groups; the increase was s
maller in patients with IGT (6.0 +/- 2.4 vs 12.3 +/- 1.6 mm Hg p < 0.0
5). Likewise, the 11.5 years' cumulative incidence of hypertension was
not significantly different in subjects with baseline IGT or normogly
caemia; if anything it was lower in the IGT group (odds ratio 0.36, 95
% CI 0.1-1.2). In multivariate analysis incidence of hypertension was
associated positively with baseline blood pressure (p < 0.0003) and ne
gatively with IGT status p < 0.03), while no significant association w
as found with insulin. In conclusion, the findings of this study quest
ion IGT as a risk factor for hypertension. Furthermore, these data do
not indicate a major role for hyperglycaemia and hyperinsulinaemia per
se in the aetiology of hypertension and suggest that IGT and hyperten
sion share one or more pathogenetic factor(s) (i.e., insulin resistanc
e, hyperactivity of the sympathetic nervous system, etc.), which induc
e deterioration of blood pressure control first, and hyperglycaemia la
ter.